These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32822721)

  • 1. A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive?
    Bennett-Lenane H; O'Shea JP; O'Driscoll CM; Griffin BT
    J Pharm Sci; 2020 Nov; 109(11):3248-3261. PubMed ID: 32822721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
    Feeney OM; Crum MF; McEvoy CL; Trevaskis NL; Williams HD; Pouton CW; Charman WN; Bergström CAS; Porter CJH
    Adv Drug Deliv Rev; 2016 Jun; 101():167-194. PubMed ID: 27089810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
    Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
    J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system.
    Williams HD; Sassene P; Kleberg K; Calderone M; Igonin A; Jule E; Vertommen J; Blundell R; Benameur H; Müllertz A; Porter CJ; Pouton CW;
    J Pharm Sci; 2014 Aug; 103(8):2441-55. PubMed ID: 24985238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of quantity of lipid based formulations with different compositions on the oral absorption of ritonavir: A trade-off between apparent solubility and permeability.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2022 Jan; 168():106079. PubMed ID: 34843915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
    Carrière F
    Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.
    Møller A; Schultz HB; Meola TR; Müllertz A; Prestidge CA
    Eur J Pharm Sci; 2021 Feb; 157():105640. PubMed ID: 33189902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tools for Early Prediction of Drug Loading in Lipid-Based Formulations.
    Alskär LC; Porter CJ; Bergström CA
    Mol Pharm; 2016 Jan; 13(1):251-61. PubMed ID: 26568134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
    Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
    Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersaturating lipid-based solid dispersion of atazanavir provides enhanced solubilization and supersaturation in the digestive aqueous phase.
    Mondal S; Sirvi A; Jadhav K; Sangamwar AT
    Int J Pharm; 2023 May; 638():122919. PubMed ID: 37011828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
    Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
    Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
    Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
    Dening TJ; Joyce P; Prestidge CA
    J Pharm Sci; 2019 Jan; 108(1):295-304. PubMed ID: 30257194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
    Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
    Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M; Imanidis G
    Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.